Samuel Chackalamannil

2.4k total citations
75 papers, 1.7k citations indexed

About

Samuel Chackalamannil is a scholar working on Organic Chemistry, Molecular Biology and Hematology. According to data from OpenAlex, Samuel Chackalamannil has authored 75 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Organic Chemistry, 30 papers in Molecular Biology and 18 papers in Hematology. Recurrent topics in Samuel Chackalamannil's work include Blood Coagulation and Thrombosis Mechanisms (18 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (12 papers) and Receptor Mechanisms and Signaling (11 papers). Samuel Chackalamannil is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (18 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (12 papers) and Receptor Mechanisms and Signaling (11 papers). Samuel Chackalamannil collaborates with scholars based in United States, United Kingdom and China. Samuel Chackalamannil's co-authors include Darı́o Doller, William J. Greenlee, George Boykow, Ho-Sam Ahn, Michael Czarniecki, Yuguang Wang, Yunsheng Hsieh, Yan Xia, Madhu Chintala and Yuguang Wang and has published in prestigious journals such as Journal of the American Chemical Society, Analytical Chemistry and Journal of Medicinal Chemistry.

In The Last Decade

Samuel Chackalamannil

75 papers receiving 1.6k citations

Peers

Countries citing papers authored by Samuel Chackalamannil

Since Specialization

Citations

This map shows the geographic impact of Samuel Chackalamannil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Chackalamannil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Chackalamannil more than expected).

Fields of papers citing papers by Samuel Chackalamannil

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel Chackalamannil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Chackalamannil. The network helps show where Samuel Chackalamannil may publish in the future.

Co-authorship network of co-authors of Samuel Chackalamannil

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel Chackalamannil. A scholar is included among the top collaborators of Samuel Chackalamannil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel Chackalamannil. Samuel Chackalamannil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of hydroxy pyrimidine Factor IXa inhibitors 2020 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), (unknown), (unknown), Martin C. Clasby, Michael P. Dwyer, Keith Eagen, (unknown), William J. Greenlee, Zhuyan Guo, Brian E. Hawes, Alan Hruza, Richard Ingram, (unknown), Santhosh Neelamkavil, Paul Reichert, Yan Xia, Samuel Chackalamannil	1
2	Discovery of nor-seco himbacine analogs as thrombin receptor antagonists 2012 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Samuel Chackalamannil, Yan Xia, Keith Eagen, William J. Greenlee, Ho-Sam Ahn, Jacqueline Agans-Fantuzzi, George Boykow, Yunsheng Hsieh, Matthew Bryant, Tze‐Ming Chan, Madhu Chintala	11
3	Azabicyclic sulfonamides as potent 11β-HSD1 inhibitors 2010 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), Samuel Chackalamannil, Hana E. Baker, Timothy J. Kowalski, Julie Lee, Giuseppe Terracina, Lili Zhang	7
4	Discovery of a vorapaxar analog with increased aqueous solubility 2010 ·Bioorganic & Medicinal Chemistry Letters ·Yan Xia, Samuel Chackalamannil, William J. Greenlee, Yuguang Wang, Zhiyong Hu, (unknown), J.K.Y. Wong, Jianshe Kong, Ho-Sam Ahn, George Boykow, Yunsheng Hsieh, Stan Kurowski, Madhu Chintala	19
5	The discovery of azepane sulfonamides as potent 11β-HSD1 inhibitors 2009 ·Bioorganic & Medicinal Chemistry Letters ·Santhosh Neelamkavil, (unknown), Samuel Chackalamannil, William J. Greenlee, Lili Zhang, Giuseppe Terracina	9
6	Himbacine derived thrombin receptor (PAR-1) antagonists: SAR of the pyridine ring 2007 ·Bioorganic & Medicinal Chemistry Letters ·Yan Xia, Samuel Chackalamannil, Martin C. Clasby, Darı́o Doller, Keith Eagen, William J. Greenlee, Hsingan Tsai, Jacqueline Agans-Fantuzzi, Ho-Sam Ahn, George Boykow, Yunsheng Hsieh, Charles A. Lunn, Madhu Chintala	4
7	Heterotricyclic Himbacine Analogs as Potent, Orally Active Thrombin Receptor (Protease Activated Receptor-1) Antagonists 2007 ·Journal of Medicinal Chemistry ·(unknown), Samuel Chackalamannil, Yan Xia, Keith Eagen, Martin C. Clasby, (unknown), William J. Greenlee, Ho-Sam Ahn, Jacqueline Agans-Fantuzzi, George Boykow, Yunsheng Hsieh, Matthew Bryant, Jairam Palamanda, Tze‐Ming Chan, David Hesk, Madhu Chintala	24
8	Thrombin Receptor (Protease Activated Receptor-1) Antagonists as Potent Antithrombotic Agents with Strong Antiplatelet Effects 2006 ·Journal of Medicinal Chemistry ·Samuel Chackalamannil	66
9	Thrombin receptor (PAR-1) antagonists as novel antithrombotic agents 2006 ·Expert Opinion on Therapeutic Patents ·Samuel Chackalamannil, Yan Xia	24
10	Discovery of Potent Orally Active Thrombin Receptor (Protease Activated Receptor 1) Antagonists as Novel Antithrombotic Agents 2005 ·Journal of Medicinal Chemistry ·Samuel Chackalamannil, Yan Xia, William J. Greenlee, Martin C. Clasby, Darı́o Doller, Hsingan Tsai, Theodros Asberom, Michael Czarniecki, Ho-Sam Ahn, George Boykow, Carolyn Foster, Jacqueline Agans-Fantuzzi, Matthew Bryant, Janice Lau, Madhu Chintala	106
11	Discovery and synthesis of a novel series of quinoline-based thrombin receptor (PAR-1) antagonists 2005 ·Bioorganic & Medicinal Chemistry Letters ·Martin C. Clasby, Samuel Chackalamannil, Michael Czarniecki, Darı́o Doller, Keith Eagen, William J. Greenlee, Lin Yan, Hsingan Tsai, Yan Xia, Ho-Sam Ahn, Jacqueline Agans-Fantuzzi, George Boykow, Madhu Chintala, Carolyn Foster, Matthew Bryant, Janice Lau	20
12	Himbacine analogs as muscarinic receptor antagonists––effects of tether and heterocyclic variations 2004 ·Bioorganic & Medicinal Chemistry Letters ·Samuel Chackalamannil, Darı́o Doller, (unknown), Vilma Ruperto	9
13	G-Protein Coupled Receptor Antagonists-1: Protease Activated Receptor-1 (PAR-1) Antagonists as Novel Cardiovascular Therapeutic Agents (Hot Topic: Structure and property Approaches in Recent Drug Discovery Guest Editor: Guo Zhu Zheng) 2003 ·Current Topics in Medicinal Chemistry ·Samuel Chackalamannil	11
14	Design and synthesis of xanthine analogues as potent and selective PDE5 inhibitors 2002 ·Bioorganic & Medicinal Chemistry Letters ·Yuguang Wang, Samuel Chackalamannil, Zhiyong Hu, (unknown), (unknown), Yan Xia, Ruo Xu, Theodros Asberom, Dmitri Pissarnitski, Andrew W. Stamford, William J. Greenlee, (unknown), (unknown), Subbarao Vemulapalli, Jairam Palamanda, Madhu Chintala, Ping Wu, (unknown), Peng Wang	29
15	Sulfide analogues as potent and selective M2 muscarinic receptor antagonists 2002 ·Bioorganic & Medicinal Chemistry Letters ·Yuguang Wang, Samuel Chackalamannil, Zhiyong Hu, Brian A. McKittrick, William J. Greenlee, Vilma Ruperto, Ruth A. Duffy, Jean E. Lachowicz	6
16	Simultaneous determination of a drug candidate and its metabolite in rat plasma samples using ultrafast monolithic column high‐performance liquid chromatography/tandem mass spectrometry 2002 ·Rapid Communications in Mass Spectrometry ·Yunsheng Hsieh, (unknown), Yuguang Wang, Samuel Chackalamannil, Jean‐Marc Brisson, Kwokei Ng, Walter A. Korfmacher	55
17	Potent, low molecular weight thrombin receptor antagonists 2001 ·Bioorganic & Medicinal Chemistry Letters ·Samuel Chackalamannil, Darı́o Doller, Keith Eagen, Michael Czarniecki, Ho-Sam Ahn, Carolyn Foster, George Boykow	13
18	A facile Diels–Alder route to dihydronaphthofuranones 2000 ·Tetrahedron Letters ·Samuel Chackalamannil, Darı́o Doller, Martin C. Clasby, Yan Xia, Keith Eagen, Lin Yan, Hsingan Tsai, Andrew T. McPhail	20
19	Design and synthesis of piperidinyl piperidine analogues as potent and selective M2 muscarinic receptor antagonists 2000 ·Bioorganic & Medicinal Chemistry Letters ·Yuguang Wang, Samuel Chackalamannil, Zhiyong Hu, John W. Clader, William J. Greenlee, William Billard, Herbert Binch, Gordon Crosby, Vilma Ruperto, Ruth A. Duffy, (unknown), Jean E. Lachowicz	85
20	Solution conformation of endothelin and point mutants by nuclear magnetic resonance spectroscopy 1992 ·International journal of peptide & protein research ·David C. Dalgarno, (unknown), Samuel Chackalamannil, Mary M. Senior	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact